Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults

被引：9

作者：

Restar, Arjee ^{[1
,2
,3
]}

Dusic, E. J. ^{[4
]}

Garrison-Desany, Henri ^{[5
]}

Lett, Elle ^{[3
,6
]}

Everhart, Avery ^{[3
,7
]}

Baker, Kellan E. ^{[5
,8
]}

Scheim, Ayden, I ^{[9
]}

Beckham, S. Wilson ^{[10
]}

Reisner, Sari ^{[11
]}

Rose, Adam J. ^{[12
]}

Mimiaga, Matthew J. ^{[13
,14
]}

Radix, Asa ^{[2
,15
,16
]}

Operario, Don ^{[17
,18
]}

Hughto, Jackie ^{[17
,18
,19
]}

机构：

[1] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA

[2] Yale Univ, Sch Publ Hlth, Dept Behav & Social Sci, New Haven, CT 06520 USA

[3] Ctr Appl Transgender Studies, Chicago, IL 60657 USA

[4] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA

[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA

[6] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[7] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Spatial Sci Inst, Populat Hlth & Pl Program, Los Angeles, CA 90007 USA

[8] Whitman Walker Inst, Washington, DC USA

[9] Drexel Univ, Dept Epidemiol & Biostat, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA

[10] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA

[11] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[12] Hebrew Univ Jerusalem, Sch Publ Hlth, Jerusalem, Israel

[13] Univ Calif Los Angeles, LGBTQ Advocacy Res & Hlth, Los Angeles, CA USA

[14] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA

[15] Columbia Univ, Dept Epidemiol, New York, NY USA

[16] Callen Lorde Community Hlth Ctr, New York, NY USA

[17] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA

[18] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA

[19] Fenway Hlth, Fenway Inst, Boston, MA USA

来源：

HUMANITIES & SOCIAL SCIENCES COMMUNICATIONS | 2022年 / 9卷 / 01期

基金：

美国国家卫生研究院;

关键词：

HEALTH-CARE; INSURANCE-COVERAGE; ADHERENCE; BARRIERS; PEOPLE; ACCESS; COMMUNICATION; NEEDS;

D O I：

10.1057/s41599-022-01291-5

中图分类号：

C [社会科学总论];

学科分类号：

03 ; 0303 ;

摘要：

Gender-affirming hormones have been shown to improve psychological functioning and quality of life among transgender and nonbinary (trans) people, yet, scant research exists regarding whether and why individuals take more or less hormones than prescribed. Drawing on survey data from 379 trans people who were prescribed hormones, we utilized multivariable logistic regression models to identify factors associated with hormone-dosing behaviors and content analysis to examine the reasons for dose modifications. Overall, 24% of trans individuals took more hormones than prescribed and 57% took less. Taking more hormones than prescribed was significantly associated with having the same provider for primary and gender-affirming care and gender-based discrimination. Income and insurance coverage barriers were significantly associated with taking less hormones than prescribed. Differences by gender identity were also observed. Addressing barriers to hormone access and cost could help to ensure safe hormone-dosing behaviors and the achievement trans people's gender-affirmation goals.

引用

页数：11

共 50 条

[1] Correction: Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults
Arjee Restar
E. J. Dusic
Henri Garrison-Desany
Elle Lett
Avery Everhart
Kellan E. Baker
Ayden I. Scheim
S. Wilson Beckham
Sari Reisner
Adam J. Rose
Matthew J. Mimiaga
Asa Radix
Don Operario
Jaclyn M. W. Hughto
[J]. Humanities and Social Sciences Communications, 9
[2] An introduction to gender-affirming hormone therapy for transgender and gender-nonbinary patients
Harris, Miles S.
Goodrum, Ashby
Krempasky, Chance N.
[J]. NURSE PRACTITIONER, 2022, 47 (03): : 18 - 28
[3] GENDER-AFFIRMING HORMONE THERAPY AND PSYCHOLOGICAL DISTRESS AMONG TRANSGENDER AND NONBINARY PEOPLE: DIFFERENCES BY SOURCE OF HORMONES
Pandey, A.
Seelman, K.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S226 - S227
[4] Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy
Leemaqz, Shalem Y.
Kyinn, Mabel
Banks, Katherine
Sarkodie, Eleanor
Goldstein, Deborah
Irwig, Michael S.
[J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (01) : 103 - 111
[5] Gender-affirming hormone therapy and cardiovascular health in transgender adults
Ong, Caroline
Monita, Monique
Liu, Minghao
[J]. CLIMACTERIC, 2024, 27 (03) : 227 - 235
[6] Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth
Green, Amy E.
DeChants, Jonah P.
Price, Myeshia N.
Davis, Carrie K.
[J]. JOURNAL OF ADOLESCENT HEALTH, 2022, 70 (04) : 643 - 649
[7] Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia
Nolan, Brendan J.
Cheung, Ada S.
[J]. INTERNAL MEDICINE JOURNAL, 2024, 54 (09) : 1450 - 1457
[8] Gender-Affirming Hormone Therapy Is Associated with Increased Odds of Screening for Sexually Transmitted Infections in a Clinical Cohort of Transgender and Nonbinary Adults
Pletta, David R.
Mayer, Kenneth H.
Chen, Jarvis T.
Hughto, Jaclyn MW.
Keuroghlian, Alex S.
Radix, Asa E.
Reisner, Sari L.
[J]. TRANSGENDER HEALTH, 2024,
[9] Gender-Affirming Hormone Therapy for Transgender Females
Randolph, John F., Jr.
[J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2018, 61 (04): : 705 - 721
[10] Gender-Affirming Hormone Therapy for Transgender Men
Moravek, Molly B.
[J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2018, 61 (04): : 687 - 704

← 1 2 3 4 5 →